Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
-
Clarion Clinics Open for Psychedelic-Assisted Treatments
-
Bombardier to Report Fourth Quarter and Full Year 2023 Financial Results, Participate in Key Investor Conferences
-
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
-
Dyne Therapeutics to Present at February Investor Conferences
-
Flow Capital Provides CrowdProperty with a $5.25 Million Loan
-
Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024
-
44 per cent chance Ottawa increases debt over 10-year period; likelihood of failure jumps to 59 per cent over 20 years
-
The Sanborn Map Company, Inc. Expands Global Presence with Launch of Sanborn Geophysics, ULC
-
Terms for Nykredit's and Totalkredit's auctions - Totalkredit A/S
-
Terms for Nykredit's and Totalkredit's auctions - Nykredit Realkredit A/S
-
Form 8.3 - [WINCANTON PLC - 31 01 2024] - (CGAML)
-
HII Reports Fourth Quarter and Full Year 2023 Results
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 31 01 2024] - (CGWL)
-
Anti-Cancer Drugs Publishes Preclinical Data Demonstrating the Broad Antineoplastic Activity of Panavance’s Misetionamide (GP-2250)
-
Watershed Announces $100M in New Funding as Corporate Climate Action Accelerates
-
NanoXplore to Host a Webcast to Discuss Second Quarter Results on February 14th, 2024
-
Gilat Awarded Multimillion-Dollar Defense Satellite Connectivity Project
-
Rogers Communications Reports Fourth Quarter 2023 Results; Announces 2024 Financial Guidance
-
Rogers Communications Declares 50 Cents per Share Quarterly Dividend
-
Allegro MicroSystems Reports Third Quarter 2024 Results
-
NP Digital Partners with Creative Agency REBL House to Propel Client Success
-
First National Corporation Reports Annual and Fourth Quarter 2023 Financial Results
-
Lithium Ionic Appoints Mike Westendorf as Vice President of Technical Services, Further Enhancing its Operational Team as it Advances Bandeira, Minas Gerais, Brazil
-
Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
-
Xali Gold Confirms SDA Plant in Mexico is Operational and Commences Bulk Sample Testing
-
Abaxx Provides Q1 Corporate Update
-
Radicle Femmes Celebrates Women in Cannabis in Toronto, Ontario
-
OneWater Marine Inc. Announces Fiscal First Quarter 2024 Results
-
Whitestone REIT Announces Fourth Quarter 2023 Earnings Webcast and Conference Call
-
Lee Enterprises reports first quarter Adjusted EBITDA growth and strong digital growth
-
Natural Gas Services Group, Inc. Announces Justin Jacobs as Chief Executive Officer
-
ITM Obtains Manufacturing License in the U.S.
-
Sandy Spring Bancorp Declares Quarterly Dividend
-
PlanSource’s 2024 Product Release Bring Benefits Engagement and AI to the Forefront
-
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024
-
Lantronix to Report Fiscal 2024 Second Quarter Results on Feb. 8, 2024
-
Bitfarms Earns 357 BTC in January 2024
-
Natural Gas Services Group, Inc. Announces Justin Jacobs as Chief Executive Officer
-
Plug Power Completes First Customer Fill of Liquid Green Hydrogen at its Georgia Plant
-
Panbela Announces Closing of Approximately $9.0 Million Public Offering
-
Kirby Corporation Announces 2023 Fourth Quarter and Full Year Results
-
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
-
Peloton Interactive, Inc. Reports Second Quarter Fiscal 2024 Financial Results
-
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
Applied UV, Inc. to Develop Smart Building Technologies for Larimar City, a New Luxury Development With Six Hotels and 20,000 High-end Residences - Potential Revenues Could Total $250 Million to $300
-
Vestaron announces CEO transition, appoints Juan Estupinan as Interim CEO
-
Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer
-
Ceridian Becomes Dayforce
-
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
